EarningsQ2 2024 Earnings Report

Iovance Biotherapeutics (2LB) Q2 2024 Earnings Report

19 Followers

DE:2LB Q2 2024 EPS Results

Actual EPS-€0.30

Consensus EPS-€0.32

Beat/MissBeat by +€0.01

One Year Ago EPS-€0.42

Actual Revenue€27.76M

Expected Revenue€21.95M

Beat/MissBeat by +€5.81M

YoY Revenue Growth+12969.75%

QuarterQ2 2024

Date08/08/2024

TimeAfter Close

Conference CallThursday, August 8, 2024

DE:2LB Upcoming Earnings

Iovance Biotherapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

DE:2LB Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-0.08 / -	-0.223	―
Aug 06, 2026	2026 (Q2)	-0.12 / -0.10	-0.295	66.67% (+0.20)
May 07, 2026	2026 (Q1)	-0.14 / -0.17	-0.321	47.22% (+0.15)
Feb 24, 2026	2025 (Q4)	-0.16 / -0.16	-0.232	30.77% (+0.07)
Nov 06, 2025	2025 (Q3)	-0.23 / -0.22	-0.25	10.71% (+0.03)
Aug 07, 2025	2025 (Q2)	-0.25 / -0.29	-0.303	2.94% (<+0.01)
May 08, 2025	2025 (Q1)	-0.22 / -0.32	-0.375	14.29% (+0.05)
Feb 27, 2025	2024 (Q4)	-0.24 / -0.23	-0.402	42.22% (+0.17)
Nov 07, 2024	2024 (Q3)	-0.27 / -0.25	-0.411	39.13% (+0.16)
Aug 08, 2024	2024 (Q2)	-0.32 / -0.30	-0.419	27.66% (+0.12)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed